• About Us
    • Company Profile
    • Mission Statement
    • Management
    • Board of Directors
  • Investors
    • Press Releases
  • Technology
    • Vaccine Platform
    • Pipeline
  • Clinical Trials
  • R & D
  • Strategic Alliances
  • Cancer Info
  • Contact
Home

Management

Leadership Team

CEO, Eric Leire, MD, MBA

Dr. Eric Leire is the company's chief executive officer. He has a solid background in vaccine, immunotherapies and clinical research.

  • Pharma experience (R&D and BD): Pfizer, Schering Plough, Pharmacia
  • Biotech experience: CEO of 2 US venture-backed biotech companies, Partner at BioStrategies (Boston)
  • Academic experience: Research Associate at the Harvard AIDS Institute
  • Fund raising experience: Partner with Biofund Ventures
  • Joined DanDrit in 2009 as board member

Head of Manufacturing, Berit Schultz

Berit Schultz is an immunologist and biologist who oversees the manufacturing activities at DanDrit. She holds a Master Sc. in Biochemistry and joined DanDrit Biotech A/S in 2007.

CFO, Investor relation, Dina R. Asmussen

Ms. Dina R. Asmussen is DanDrit® Biotech's former chief executive officer. She holds a Master Sc. Economics from Copenhagen Business School.

  • Master of Finance from CBS
  • Fund management experience +15 years from Bank and Investment Funds
  • Responsible for setting up several Pharma- and Biotech Funds
  • Certificate from Board Governance - Strategic Board Room
  • Founding CEO of DanDrit Biotech

DanDrit Biotech A/S • Høffdingsvej 34 • 2500 Valby • info@dandrit.com • Disclaimer